Follow
Peter Stachon
Peter Stachon
University Heart Center Freiburg
Verified email at universitaets-herzzentrum.de
Title
Cited by
Cited by
Year
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis—but does not affect immunity and thrombosis in mice
D Wolf, JD Hohmann, A Wiedemann, K Bledzka, H Blankenbach, ...
Circulation research 109 (11), 1269-1279, 2011
1002011
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense
D Wolf, N Anto-Michel, H Blankenbach, A Wiedemann, K Buscher, ...
Nature communications 9 (1), 1-11, 2018
742018
Tumor necrosis factor receptor–associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall
A Missiou, N Köstlin, N Varo, P Rudolf, P Aichele, S Ernst, C Münkel, ...
Circulation 121 (18), 2033-2044, 2010
742010
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
A Supady, E Weber, M Rieder, A Lother, T Niklaus, T Zahn, F Frech, ...
The Lancet Respiratory medicine 9 (7), 755-762, 2021
642021
P2X7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice
P Stachon, A Heidenreich, J Merz, I Hilgendorf, D Wolf, F Willecke, ...
Circulation 135 (25), 2524-2533, 2017
642017
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
I Hilgendorf, S Eisele, I Remer, J Schmitz, K Zeschky, C Colberg, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (9), 1991-1999, 2011
612011
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation
A Missiou, P Rudolf, P Stachon, D Wolf, N Varo, P Aichele, C Colberg, ...
Circulation research 107 (6), 757-766, 2010
572010
Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice
D Wolf, F Jehle, NA Michel, EN Bukosza, J Rivera, YC Chen, N Hoppe, ...
Circulation 129 (23), 2414-2425, 2014
562014
Inflammatory mechanisms in atherosclerosis
D Wolf, P Stachon, C Bode, A Zirlik
Hämostaseologie 34 (01), 63-71, 2014
552014
Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B100–Reactive CD4+ T-Regulatory Cells
D Wolf, T Gerhardt, H Winkels, NA Michel, AB Pramod, Y Ghosheh, ...
Circulation 142 (13), 1279-1293, 2020
532020
P2Y6 Deficiency Limits Vascular Inflammation and Atherosclerosis in Mice
P Stachon, A Peikert, NA Michel, S Hergeth, T Marchini, D Wolf, B Dufner, ...
Arteriosclerosis, thrombosis, and vascular biology 34 (10), 2237-2245, 2014
522014
Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice
P Stachon, S Geis, A Peikert, A Heidenreich, NA Michel, F Ünal, N Hoppe, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 36 (8), 1577-1586, 2016
512016
CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies
D Wolf, F Jehle, A Ortiz Rodriguez, B Dufner, N Hoppe, C Colberg, ...
PloS one 7 (3), e33026, 2012
432012
Purinergic receptor Y2 (P2Y2)-dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome
J Merz, P Albrecht, S von Garlen, I Ahmed, D Dimanski, D Wolf, ...
Basic research in cardiology 113 (6), 1-11, 2018
422018
Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography
P Stachon, K Kaier, S Milde, G Pache, S Sorg, M Siepe, C von zur Mühlen, ...
European Heart Journal-Cardiovascular Imaging 16 (7), 731-737, 2015
342015
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
A Peikert, K Kaier, J Merz, L Manhart, I Schäfer, I Hilgendorf, P Hehn, ...
Clinical Research in Cardiology 109 (3), 315-323, 2020
312020
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression
A Lindau, C Härdtner, SP Hergeth, KD Blanz, B Dufner, N Hoppe, ...
Basic research in cardiology 111 (2), 1-11, 2016
312016
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice
J Pennig, P Scherrer, MC Gissler, N Anto-Michel, N Hoppe, L Füner, ...
Scientific reports 9 (1), 1-12, 2019
302019
Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans
P Stachon, A Missiou, C Walter, N Varo, C Colberg, D Wolf, M Buchner, ...
PloS one 5 (7), e11589, 2010
262010
Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation
J Rilinger, V Zotzmann, X Bemtgen, C Schumacher, PM Biever, ...
Critical Care 24 (1), 1-9, 2020
252020
The system can't perform the operation now. Try again later.
Articles 1–20